Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 2, 2022
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in FranceOlivier Fain, Aurelie Du-Thanh, Delphine Gobert, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 27, 2021
COVID-19 as a trigger of acute attacks in people with hereditary angioedemaAude Belbézier, Mélanie Arnaud, Isabelle Boccon-Gibod, et al.
Frontiers in Immunology|March 2, 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committeeMauro Cancian, Teresa Caballero, Isabelle Boccon-Gibod, et al.
Clinical Reviews in Allergy & Immunology|April 1, 2021
The Global Registry for Hereditary Angioedema due to C1-Inhibitor DeficiencyAndrea Zanichelli, Henriette Farkas, Laurance Bouillet, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 14, 2022
Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case seriesMarcus Maurer, Markus Magerl, Emel Aygören-Pürsün, et al.
European Journal of Dermatology : EJD|November 1, 2017
Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticariaMarta Ferrer, Isabelle Boccon-Gibod, Margarida Gonçalo, et al.
American Journal of Obstetrics and Gynecology|June 17, 2008
Disease expression in women with hereditary angioedemaLaurence Bouillet, Hilary Longhurst, Isabelle Boccon-Gibod, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|February 26, 2015
Bradykinin-mediated angioedema: factors associated with admission to an intensive care unit, a multicenter studyNicolas Javaud, Bernard Floccard, Florian Gontier, et al.
Pageof 6